[1]
“Formulation and in-vitro characterization of erythromycin ocular inserts”, Int. J. Res. Pharm. Sci. Technol., vol. 3, no. 4, pp. 44–50, Nov. 2020, doi: 10.33974/ijrpst.v2i2.245.